RMD Fair Value Estimate
$331.3158.2% undervalued
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Resmed Inc
Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Did you know?
Earnings per share grew at a 23.0% CAGR.
Current Price
$209.43
+2.15%GoodMoat Value
$331.31
58.2% undervaluedProfile
Valuation (TTM)
Market Cap$30.51B
P/E20.08
EV$32.71B
P/B5.11
Shares Out145.68M
P/Sales5.51
Revenue$5.54B
EV/EBITDA13.90
Resmed Inc (RMD) Valuation
RMD Valuation Metrics
FCF$1.66B
FCF Growth Rate27.31%
EPS Growth (CAGR)23.00%
WACC10.00%
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →RMD Valuation & Fair Value Analysis
Resmed Inc (RMD) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Resmed Inc is $331.31. The current stock price is $209.43, suggesting the stock is 58.2% undervalued.
The price-to-earnings (P/E) ratio is 20.08. Price-to-book ratio is 5.11. Price-to-sales ratio is 5.51. Enterprise value to EBITDA is 13.90. PEG ratio is 2.00.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Resmed Inc's intrinsic value.